Substituted indazole derivatives active as kinase inhibitors
US9616059B2 · kind B2 · utility
4Cited by
5References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 16, 2015 |
| Grant date | Apr 11, 2017 |
| Priority date | — |
| Expiry date | Dec 16, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Substituted indazole derivatives of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification; the compounds of the invention may be useful in therapy in the treatment of diseases associated with a deregulated protein kinase activity, like cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.